Attenuation Changes in ASPECTS Regions: A Surrogate for CT Perfusion-based Ischemic Core in Acute Ischemic Stroke.


Journal

Radiology
ISSN: 1527-1315
Titre abrégé: Radiology
Pays: United States
ID NLM: 0401260

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 20 3 2019
medline: 31 1 2020
entrez: 20 3 2019
Statut: ppublish

Résumé

Background Recent studies have proven the effectiveness of thrombectomy up to 24 hours after stroke onset for patients with specific criteria at advanced CT or MRI. Clinical implementation of treatment in this extended time window remains a challenge, as many stroke centers do not routinely use advanced imaging. Purpose To determine whether automated cerebral x-ray attenuation measurements at noncontrast CT provide information on the presence of CT perfusion-defined ischemic core as applied in late time windows for thrombectomy. Materials and Methods In this retrospective study, patients with middle cerebral artery stroke due to proximal occlusion from 2009 to 2017 were included. All patients underwent noncontrast CT and CT perfusion. Automated software was used to calculate relative Hounsfield unit (rHU) values for Alberta Stroke Program Early CT Score (ASPECTS) regions on noncontrast CT images as the ratio of x-ray attenuation between ischemic versus non-ischemic hemispheres. Sensitivity, specificity, and diagnostic performance of rHU and composite rHU-ASPECTS, a score incorporating rHU from all regions, were analyzed for the classification of regional ischemic core and late time window thrombectomy criteria at CT perfusion. Results Data in a total of 200 patients were evaluated (105 women [mean age, 74 years ± 14 {standard deviation}] and 95 men [mean age, 76 years ± 14]). There were 121 patients in the validation cohort and 79 patients in the independent test cohort. Compared among all examined regions, rHU values yielded the best classification of ischemic core for the caudate nucleus, the lentiform nucleus, and the insula (with areas under the receiver operating characteristic curve [AUCs] ranging from 0.70 to 0.77;

Identifiants

pubmed: 30888935
doi: 10.1148/radiol.2019182041
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-458

Auteurs

Paul Reidler (P)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

Kolja M Thierfelder (KM)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

Lukas T Rotkopf (LT)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

Matthias P Fabritius (MP)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

Daniel Puhr-Westerheide (D)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

Franziska Dorn (F)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

Nils D Forkert (ND)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

André Kemmling (A)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

Wolfgang G Kunz (WG)

From the Departments of Radiology (P.R., L.T.R., M.P.F., D.P., W.G.K.) and Neuroradiology (F.D.), University Hospital, LMU Munich, Marchioninistr 15, 81377 Munich, Germany; Institute for Diagnostic and Interventional Radiology, University Medical Center Rostock, Rostock, Germany (K.M.T.); Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Canada (N.D.F., W.G.K.); and Department of Neuroradiology, University Hospital Schleswig-Holstein, Luebeck, Germany (A.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH